EUVIMEDEUVIMED entdecken
Open Access

Dutasteride-loaded nanostructured lipid carrier for androgenic alopecia treatment – An in vivo study

Saman Heydari iD, Mohammad Barzegar Jalali, Maryam Kouhsoltani, Afsaneh Radmehr, Ana Cláudia Paiva-Santos, Siamak Barghi, Hamed Hamishehkar iD

BioImpacts · 10.05.2026 · 16 · 30245

DOI: 10.34172/bi.30245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioImpacts, online erschienen am 10.05.2026. Verfasst von Saman Heydari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Androgenic alopecia (AGA) is the most common type of hair loss that occurs due to androgens, specially, dihydrotestosterone (DHT), and the 5-alpha reductase is the key enzyme to control AGA, as it is responsible for the conversion of testosterone to DHT, the more potent form of testosterone involved in the pathogenesis of AGA. Blockers of this enzyme suppress the conversion of androgens to DHT. Dutasteride is one of the 5-alpha reductase inhibitors and is frequently used as an anti-hair loss treatment. Gamma-oryzanol (GO) is an anti-oxidant and anti-5-alpha reductase, which has been introduced as an anti-hair loss treatment by some studies.

Methods

The nanostructured lipid carriers (NLCs) were developed for targeting the dutasteride and GO in hair follicles. The NLCs were prepared from herbal oils pumpkin seed oil (PSO) and saw palmetto (SP), which also have a 5-alpha reductase inhibitory effect, contributing to the therapeutic effect. NLCs in follicular targeting enable to accumulation of the drugs in the target area (hair follicle cells), reduce the absorption of dutasteride in other organs and tissues, and reduce the side effects. NLCs were prepared by adopting a hot homogenization method and were characterized by particle size analyzer, scanning electron microscope, and X-ray diffraction. An in-vivo study was conducted using C57BL/6 mice to assess NLCs ability in drug delivery and accumulation in hair follicles.

Results

NLCs had great potentials for reducing the dutasteride daily dose. Moreover, the accumulation of NLCs was confirmed by histopathological images even after two weeks of the discontinued treatment.

Conclusion

NLCs may have facilitated the follicular delivery of the anti-hair loss drugs. Since the NLCs have potential for accumulation in the hair follicles, the interval of formulation usage may have been increased to more than once a week which was of great interest to the practitioners aiming at developing more efficient formulations for androgenetic alopecia.

Schlagwörter

Stichwörter der Autor:innen

Androgenic alopeciaDutasterideFollicular drug deliveryGamma-oryzanolNanostructured lipid carriers

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Student Research Committee and Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Biotechnology Research Center and Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Oral and Maxillofacial Pathology, School of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Dermatology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Coimbra, Portugal.

ORCID-Profile: Saman Heydari, Hamed Hamishehkar

Zitieren

APA

Heydari, S., Barzegar Jalali, M., Kouhsoltani, M., Radmehr, A., Paiva-Santos, A. C., Barghi, S., & Hamishehkar, H. (2026). Dutasteride-loaded nanostructured lipid carrier for androgenic alopecia treatment – An in vivo study. BioImpacts, 16, 30245. https://doi.org/10.34172/bi.30245

Vancouver

Heydari S, Barzegar Jalali M, Kouhsoltani M, Radmehr A, Paiva-Santos AC, Barghi S, et al. Dutasteride-loaded nanostructured lipid carrier for androgenic alopecia treatment – An in vivo study. BioImpacts. 2026;16:30245. doi:10.34172/bi.30245

BibTeX
@article{Heydari2026,
  author = {Heydari, Saman and Barzegar Jalali, Mohammad and Kouhsoltani, Maryam and Radmehr, Afsaneh and Paiva-Santos, Ana Cláudia and Barghi, Siamak and Hamishehkar, Hamed},
  title = {Dutasteride-loaded nanostructured lipid carrier for androgenic alopecia treatment – An in vivo study},
  journal = {BioImpacts},
  year = {2026},
  volume = {16},
  pages = {30245},
  doi = {10.34172/bi.30245}
}
Kostenlos starten →